Loading clinical trials...
Loading clinical trials...
A Phase II, Multi-centre, Two-part Study to Evaluate the Safety and Efficacy of Study Drug in Acute Ischaemic Stroke.
Conditions
Interventions
V10153
Locations
28
United States
Stroke Centre, Mayo Clinic
Scottsdale, Arizona, United States
UCLA Stroke Network
Los Angeles, California, United States
Neurology Medical Group of Diablo Valley
Walnut Creek, California, United States
Bethesda Memorial Hospital
Boynton Beach, Florida, United States
Bradenton Research Centre
Bradenton, Florida, United States
Ocala Neurodiagnostic Centre
Ocala, Florida, United States
Start Date
August 1, 2005
Primary Completion Date
November 1, 2008
Completion Date
March 1, 2009
Last Updated
June 3, 2016
NCT06258538
NCT05093673
NCT07371455
NCT07253181
NCT06870812
NCT04119544
Lead Sponsor
Vernalis (R&D) Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions